Largest biotech companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 20 biotech companies in the United States ranked by earnings, at SGD 11B, ahead of Amgen (SGD 9.9B) and Biogen (SGD 1.7B). Figures as of 20 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- Gilead SciencesSGD 11B
- Median
- -SGD 88.4M
- Combined market value
- SGD 947.2B
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SGD 11B | SGD 266.2B | SGD 214.64 | 1.45% down | 31% up | ||
| 2 | AmgenAMGN · Health Care | SGD 9.9B | SGD 305.9B | SGD 565.59 | 1.14% down | 30% up | ||
| 3 | BiogenBIIB · Health Care | SGD 1.7B | SGD 47.1B | SGD 318.52 | 1.70% down | 41% up | ||
| 4 | ExelixisEXEL · Health Care | SGD 1B | SGD 20.7B | SGD 84.85 | 3.60% down | 55% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | SGD 616.9M | SGD 20.4B | SGD 201.83 | 3.85% down | 10% up | ||
| 6 | Halozyme TherapeuticsHALO · Health Care | SGD 408.4M | SGD 13.7B | SGD 119.92 | 2.88% down | 32% up | ||
| 7 | Krystal BiotechKRYS · Health Care | SGD 264M | SGD 12.1B | SGD 407.05 | 0.15% up | 49% up | ||
| 8 | Bio-TechneTECH · Health Care | SGD 234.4M | SGD 14.7B | SGD 93.70 | 0.07% down | 18% up | ||
| 9 | RepligenRGEN · Health Care | SGD 63M | SGD 14B | SGD 219.48 | 1.38% down | 5% up | ||
| 10 | Adaptive BiotechnologiesADPT · Health Care | -SGD 76.7M | SGD 5.9B | SGD 36.15 | 1.44% down | 51% up | ||
| 11 | Twist BioscienceTWST · Health Care | -SGD 100.1M | SGD 9.8B | SGD 143.86 | 4.07% down | 291% up | ||
| 12 | CG OncologyCGON · Health Care | -SGD 207.5M | SGD 9.4B | SGD 105.56 | 2.38% up | 93% up | ||
| 13 | Kodiak SciencesKOD · Health Care | -SGD 296.4M | SGD 8.3B | SGD 126.18 | 0.09% up | 371% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | -SGD 401.3M | SGD 13.1B | SGD 153.88 | 1.44% down | 81% up | ||
| 15 | ImmunityBioIBRX · Health Care | -SGD 452.9M | SGD 9B | SGD 8.47 | 1.94% down | 216% up | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | -SGD 487.1M | SGD 7.9B | SGD 64.92 | 4.94% up | 25% up | ||
| 17 | ImmunovantIMVT · Health Care | -SGD 651.7M | SGD 8.7B | SGD 41.91 | 1.96% down | 44% up | ||
| 18 | VaxcytePCVX · Health Care | -SGD 988.1M | SGD 11.9B | SGD 75.22 | 0.27% down | 22% up | ||
| 19 | Revolution MedicinesRVMD · Health Care | -SGD 1.5B | SGD 44.4B | SGD 205.49 | 0.24% down | 125% up | ||
| 20 | ModernaMRNA · Health Care | -SGD 3.6B | SGD 104B | SGD 256.91 | 1.29% up | 740% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2889 SGD).
Questions and answers
Which biotech companies in the United States rank first by earnings?
Gilead Sciences (SGD 11B), Amgen (SGD 9.9B) and Biogen (SGD 1.7B) are the top three of the 20 biotech companies in the United States ranked by earnings as of 20 Nov 2026, 14:23 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by earnings.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by earnings have a combined market value of SGD 947.2B as of 20 Nov 2026, 14:23 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.